Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- David Gordon
- , Peter Kelley
- , Susanne Heinzel
- , Peter Cooper
- , Nikolai Petrovsky
Research output: Contribution to journal › Article › peer-review
97
Citations
(Scopus)